-
Something wrong with this record ?
Combined efficacy of Cinnamomum zeylanicum and doxorubicin against leukemia through regulation of TRAIL and NF-kappa B pathways in rat model
S. Bukhari, MH. Siddique, A. Naeem, I. Khan, Z. Ali, A. Essa, F. Fazal, RA. Anis, L. Moran, A. Sultan, I. Murtaza, P. Vanhara, M. Anees
Language English Country Netherlands
Document type Journal Article
Grant support
URF
Quaid-i-Azam University
NLK
ProQuest Central
from 1997-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2011-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 1997-01-01 to 1 year ago
- MeSH
- Apoptosis MeSH
- Benzene pharmacology MeSH
- Doxorubicin pharmacology MeSH
- Rats MeSH
- Leukemia * drug therapy MeSH
- NF-kappa B metabolism MeSH
- Oils, Volatile * pharmacology MeSH
- Rats, Sprague-Dawley MeSH
- TNF-Related Apoptosis-Inducing Ligand metabolism pharmacology MeSH
- Cinnamomum zeylanicum metabolism MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
BACKGROUND: Recent discoveries in cancer therapeutics have proven combination therapies more effective than individual drugs. This study describes the efficacy of the combination of Cinnamomum zeylanicum and doxorubicin against benzene-induced leukemia. METHODS AND RESULTS: Brine shrimp assay was used to assess the cytotoxicity of C. zeylanicum, doxorubicin and their combination. After AML induction in Sprague Dawley rats, the same drugs were given to rat groups. Changes in organ weight, haematological profile, and hepatic enzymes were determined. Real-time PCR was used to elucidate the effect on the expression of STMN1, GAPDH, P53 and various TRAIL and NF-kappaB components. C. zeylanicum reduced the cytotoxicity of doxorubicin. The combination treatment showed better anti-leukemic results than any of the individual drugs as evident from STMN1 expression (p < 0.001). It was particularly effective in reducing total white blood cell counts and recovering lymphocytes, monocytes and eosinophils along with hepatic enzymes ALT and AST (p < 0.001). All doses recovered relative organ weights and improved blood parameters. The combination therapy was particularly effective in inducing apoptosis, inhibition of proliferation marker GAPDH (p < 0.001) and NF-kappaB pathway components Rel-A (p < 0.001) and Rel-B (p < 0.01). Expressions of TRAIL components c-FLIP (p < 0.001), TRAIL ligand (p < 0.001) and caspase 8 (p < 0.01) were also altered. CONCLUSION: Cinnamomum zeylanicum in combination with doxorubicin helps to counter benzene-induced cellular and hepatic toxicity and improves haematological profile. The anti-leukemic effects are potentially due to inhibition of GAPDH and NF-kappa B pathway, and through regulation of TRAIL pathway. Our data suggests the use of C. zeylanicum with doxorubicin to improve anti-leukemic therapeutic regimes.
Department of Biochemistry Quaid i Azam University Islamabad 45320 Pakistan
Department of Diet and Nutritional Sciences Ibadat International University Islamabad Pakistan
Department of Histology and Embryology Faculty of Medicine Masaryk University Brno Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22025349
- 003
- CZ-PrNML
- 005
- 20240111102118.0
- 007
- ta
- 008
- 221017s2022 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11033-022-07478-y $2 doi
- 035 __
- $a (PubMed)35579734
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Bukhari, Sidra $u Department of Biochemistry, Quaid-i-Azam University, Islamabad, 45320, Pakistan $1 https://orcid.org/http://orcid.org/0000000193085442
- 245 10
- $a Combined efficacy of Cinnamomum zeylanicum and doxorubicin against leukemia through regulation of TRAIL and NF-kappa B pathways in rat model / $c S. Bukhari, MH. Siddique, A. Naeem, I. Khan, Z. Ali, A. Essa, F. Fazal, RA. Anis, L. Moran, A. Sultan, I. Murtaza, P. Vanhara, M. Anees
- 520 9_
- $a BACKGROUND: Recent discoveries in cancer therapeutics have proven combination therapies more effective than individual drugs. This study describes the efficacy of the combination of Cinnamomum zeylanicum and doxorubicin against benzene-induced leukemia. METHODS AND RESULTS: Brine shrimp assay was used to assess the cytotoxicity of C. zeylanicum, doxorubicin and their combination. After AML induction in Sprague Dawley rats, the same drugs were given to rat groups. Changes in organ weight, haematological profile, and hepatic enzymes were determined. Real-time PCR was used to elucidate the effect on the expression of STMN1, GAPDH, P53 and various TRAIL and NF-kappaB components. C. zeylanicum reduced the cytotoxicity of doxorubicin. The combination treatment showed better anti-leukemic results than any of the individual drugs as evident from STMN1 expression (p < 0.001). It was particularly effective in reducing total white blood cell counts and recovering lymphocytes, monocytes and eosinophils along with hepatic enzymes ALT and AST (p < 0.001). All doses recovered relative organ weights and improved blood parameters. The combination therapy was particularly effective in inducing apoptosis, inhibition of proliferation marker GAPDH (p < 0.001) and NF-kappaB pathway components Rel-A (p < 0.001) and Rel-B (p < 0.01). Expressions of TRAIL components c-FLIP (p < 0.001), TRAIL ligand (p < 0.001) and caspase 8 (p < 0.01) were also altered. CONCLUSION: Cinnamomum zeylanicum in combination with doxorubicin helps to counter benzene-induced cellular and hepatic toxicity and improves haematological profile. The anti-leukemic effects are potentially due to inhibition of GAPDH and NF-kappa B pathway, and through regulation of TRAIL pathway. Our data suggests the use of C. zeylanicum with doxorubicin to improve anti-leukemic therapeutic regimes.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a apoptóza $7 D017209
- 650 _2
- $a benzen $x farmakologie $7 D001554
- 650 _2
- $a skořicovník ceylonský $x metabolismus $7 D002935
- 650 _2
- $a doxorubicin $x farmakologie $7 D004317
- 650 12
- $a leukemie $x farmakoterapie $7 D007938
- 650 _2
- $a NF-kappa B $x metabolismus $7 D016328
- 650 12
- $a oleje prchavé $x farmakologie $7 D009822
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Sprague-Dawley $7 D017207
- 650 _2
- $a protein TRAIL $x metabolismus $x farmakologie $7 D053221
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Siddique, Muhammad Hamid $u Department of Biochemistry, Quaid-i-Azam University, Islamabad, 45320, Pakistan $1 https://orcid.org/http://orcid.org/0000000262209550
- 700 1_
- $a Naeem, Anum $u Department of Biochemistry, Quaid-i-Azam University, Islamabad, 45320, Pakistan $1 https://orcid.org/http://orcid.org/0000000185722464
- 700 1_
- $a Khan, InamUllah $u Department of Biochemistry, Quaid-i-Azam University, Islamabad, 45320, Pakistan $1 https://orcid.org/http://orcid.org/0000000187195020
- 700 1_
- $a Ali, Zain $u Department of Biochemistry, Quaid-i-Azam University, Islamabad, 45320, Pakistan $1 https://orcid.org/http://orcid.org/0000000155791127
- 700 1_
- $a Essa, Asiya $u Department of Biochemistry, Quaid-i-Azam University, Islamabad, 45320, Pakistan $1 https://orcid.org/http://orcid.org/0000000160133815
- 700 1_
- $a Fazal, Falak $u Department of Biochemistry, Quaid-i-Azam University, Islamabad, 45320, Pakistan
- 700 1_
- $a Anis, Riffat Aysha $u Department of Diet and Nutritional Sciences, Ibadat International University, Islamabad, Pakistan
- 700 1_
- $a Moráň, Lukáš $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0312627
- 700 1_
- $a Sultan, Aneesa $u Department of Biochemistry, Quaid-i-Azam University, Islamabad, 45320, Pakistan
- 700 1_
- $a Murtaza, Iram $u Department of Biochemistry, Quaid-i-Azam University, Islamabad, 45320, Pakistan
- 700 1_
- $a Vanhara, Petr $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Anees, Mariam $u Department of Biochemistry, Quaid-i-Azam University, Islamabad, 45320, Pakistan. mariam@qau.edu.pk $1 https://orcid.org/http://orcid.org/0000000190494718
- 773 0_
- $w MED00003392 $t Molecular biology reports $x 1573-4978 $g Roč. 49, č. 7 (2022), s. 6495-6507
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35579734 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20221017 $b ABA008
- 991 __
- $a 20240111102113 $b ABA008
- 999 __
- $a ok $b bmc $g 1854857 $s 1176639
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 49 $c 7 $d 6495-6507 $e 20220517 $i 1573-4978 $m Molecular biology reports $n Mol Biol Rep $x MED00003392
- GRA __
- $a URF $p Quaid-i-Azam University
- LZP __
- $a Pubmed-20221017
